increased risk of fetal oral clefts with lamotrigine (Lamictal) use during the first trimester
Health Canada is warning of possible increased risk of fetal oral clefts with lamotrigine (Lamictal) use during the first trimester.
This data comes from North American pregnancy registries... and experts are now assessing pregnancy registries around the world.
So far there's no clear proof of an overall increased risk of MAJOR malformations.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote